Saturday, September 12, 2026
spot_img

Kalmar Corporation signed EUR 200 million revolving credit facility

KALMAR CORPORATION, PRESS RELEASE, 13 DECEMBER 2024 AT 17:00 PM (EET) 

Kalmar Corporation signed EUR 200 million revolving credit facility

Kalmar Corporation has entered into a EUR 200 million revolving credit facility with a syndicate of its six relationship banks on 13 December 2024. The facility has a tenor of five years with two one-year extension options subject to the lenders’ approval. The purpose of this facility is to refinance the existing EUR 150 million euros bilateral revolving credit facilities maturing in 2025 and 2027 and general corporate purposes of the group.  
With this facility, Kalmar strengthens its long-term liquidity position. 
The facility was coordinated by SEB and the Mandated Lead Arrangers and Bookrunners are BNP Paribas, Danske Bank, Nordea Bank, OP Corporate Bank, SEB (Facility Agent) and Standard Chartered Bank.

For further information, please contact:
Sakari Ahdekivi, CFO, tel. +358 50 400 3557
Ilari Pajunen, Vice President, Treasury, puh. +358 20 777 4000

About Kalmar
Kalmar (Nasdaq Helsinki: KALMAR) is moving goods in critical supply chains around the world, with the vision to be the forerunner in sustainable material handling equipment and services. The company offers a wide range of industry shaping heavy material handling equipment and services to ports and terminals, distribution centres, manufacturing and heavy logistics. Headquartered in Helsinki, Finland, Kalmar operates globally in over 120 countries and employs approximately 5,200 people. In 2023, the company’s sales totalled approximately EUR 2.0 billion. www.kalmarglobal.com

Powered by SlickText.com

Hot this week

Capgemini signs a definitive agreement to sell Capgemini Government Solutions

Media RelationsSam ConnattyTel.: +44 (0) 7811 486517E-Mail: [email protected] ...

Michelin | Disclosure of the total number of voting rights and of the number of shares making up the company’s capital

Clermont-Ferrand, September 11th, 2026 COMPAGNIE GÉNÉRALE DES...

Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial

Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) --...

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

  TARPON SPRINGS, Fla., September 11, 2026 –...

Exodus Movement, Inc. August 2026 — Monthly Metrics

OMAHA, Neb., Sept. 11, 2026 (GLOBE NEWSWIRE) --...

Topics

spot_img

Related Articles

Popular Categories

spot_img